Becton, Dickinson(BDX)

Search documents
Becton, Dickinson(BDX) - 2021 Q2 - Earnings Call Presentation
2021-05-06 17:55
| --- | --- | |------------------------------------------|-------| | | | | | | | | | | | | | | | | Creating value by fulfilling our purpose | | | Advancing the World of Health ™ | | | May 6, 2021 | | Caution Concerning Forward-Looking Statements This presentation contains certain estimates and other forward-looking statements (as defined under Federal securities laws) regarding BD's future prospects and performance, including, but not limited to, future revenues, earnings per share, leverage targets, capita ...
Becton, Dickinson(BDX) - 2021 Q2 - Quarterly Report
2021-05-05 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-4802 Becton, Dickinson and Company (Exact name of registrant as specified in its charter) New Jersey 22-0760120 (State or other ...
Becton, Dickinson(BDX) - 2021 Q1 - Earnings Call Transcript
2021-02-04 18:49
Becton, Dickinson and Company (NYSE:BDX) Q1 2021 Results Conference Call February 4, 2021 8:00 AM ET Company Participants Kristen Stewart - Senior Vice President Strategy and Investor Relations Thomas Polen - President and Chief Executive Officer Christopher Reidy - Chief Financial Officer and Chief Administrative Officer Dave Hickey - President of Life Sciences Simon Campion - President of Interventional Conference Call Participants David Lewis - Morgan Stanley Robert Marcus - JPMorgan Chase & Co Vijay Ku ...
Becton, Dickinson(BDX) - 2021 Q1 - Earnings Call Presentation
2021-02-04 14:45
| --- | --- | |---------------------------------|-------| | | | | | | | | | | | | | | | | | | | Q1 FY2021 | | | Overview & Financial Supplement | | | February 4, 2021 | | | 1 | | Disclaimer 2 Caution Concerning Forward-Looking Statements This presentation contains certain estimates and other forward-looking statements (as defined under Federal securities laws) regarding BD's future prospects and performance, including, but not limited to, future revenues, margins, and earnings per share, leverage targets, c ...
Becton, Dickinson(BDX) - 2021 Q1 - Quarterly Report
2021-02-03 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-4802 Becton, Dickinson and Company (Exact name of registrant as specified in its charter) New Jersey 22-0760120 (State or oth ...
Becton Dickinson (BDX) Presents At 39th Annual J.P. Morgan Healthcare Conference - Slideshow
2021-01-20 11:49
Driving Value Creation through Fulfilling our Purpose Tom Polen CEO and President 39th Annual J.P. Morgan Conference January 12, 2021 Caution Concerning Forward-Looking Statements 2 This presentation contains certain estimates and other forward-looking statements (as defined under Federal securities laws) regarding BD's future prospects and performance, including, but not limited to, future revenues, margins, and earnings per share, leverage targets, capital deployment and total return targets. All such sta ...
Becton, Dickinson(BDX) - 2020 Q4 - Annual Report
2020-11-25 19:21
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NUMBER: 001-4802 BECTON, DICKINSON AND COMPANY (Exact name of registrant as specified in its charter) New Jersey 22-0760120 (Sta ...
Becton, Dickinson(BDX) - 2020 Q4 - Earnings Call Transcript
2020-11-05 22:53
Becton, Dickinson and Company (NYSE:BDX) Q4 2020 Earnings Conference Call November 5, 2020 8:00 AM ET Company Participants Kristen Stewart - Senior Vice President of Strategy and Investor Relations Thomas Polen - President and Chief Executive Officer Christopher Reidy - Executive Vice President, Chief Financial Officer and Chief Administrative Officer Simon Campion - Executive Vice President and President of Interventional Segment Conference Call Participants Robert Hopkins - Bank of America Merrill Lynch D ...
Becton, Dickinson(BDX) - 2020 Q4 - Earnings Call Presentation
2020-11-05 13:16
Advancing the world of health™ November 5, 2020 BD and the BD Logo are trademarks of Becton, Dickinson and Company © 2020 BD and its subsidiaries All rights reserved Caution Concerning Forward-Looking Statements This document contains certain estimates and other forward-looking statements (as defined under Federal securities laws) regarding BD's performance, including future revenues and earnings per share. All such statements are based upon current expectations of BD and involve a number of business risks ...
Becton, Dickinson(BDX) - 2020 Q3 - Quarterly Report
2020-08-06 19:25
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-4802 Becton, Dickinson and Company (Exact name of registrant as specified in its charter) New Jersey 22-0760120 (State or other j ...